In a cross-sectional study carboxyhaemoglobin (COHb) levels in tobacco smokers were found to provide a better indication of a person's risk of having developed certain atherosclerotic diseases, including ischaemic heart disease, than the smoking history. In the age group 30-69 years a person with a COHb level of 5% or more was found to be 21 times (lower 95% confidence limit 33 times) as likely to be affected by these diseases as another person of the same age and sex with similar smoldng history and current smoking habits but with a COHb level of less than 3%.
Introduction
There is a well recognized correlation between smoking and atherosclerosis. Prospective American studies have shown that men aged 40-49 who smoke 40 cigarettes a day have five times the risk of dying from ischaemic heart disease compared with non-smokers (Hammond, 1972) . British data have shown that moderate cigarette smoking (more than 15 a day) trebles the risk of dying from ischaemic heart disease in men aged 45-54 (Doll and Hill, 1964) .
A smoker's risk of developing atherosclerosis is likely to be more closely related to the amount of tobacco smoke absorbed than to the amount of tobacco smoked. Carboxyhaemoglobin (COHb) can be used as a measure of tobacco smoke absorption since carbon monoxide (CO) is present in tobacco smoke in concentrations of about 4% (Wynder and Hoffman, 1967) . It readily diffuses through the lungs and is avidly taken up by haemoglobin to form the stable pigment COHb. The percentage COHb saturation is determined by a number of factors, including tobacco consumption, concentration of CO in tobacco smoke, depth of inhaling, CO pulmonary transfer factor, and atmospheric CO levels. Atmospheric CO very rarely results in COHb levels above 2-5% (Lawther and Commins, 1970) . Values above this are usually the result of smoking and may reach 15% in heavy smokers (Goldsmith, 1970) .
A COHb value provides information on tobacco smoke absorption, and therefore incorporates information on depth of inhaling as well as recent tobacco consumption. Ideally, a blood marker of daily tobacco smoke absorption should remain constant throughout the day for a given exposure to tobacco smoke. However, COHb has a half-life of only about four hours in resting men breathing air (Roughton and Root, 1945) , so allowance must be made for this loss or the timing of the estimation standardized in relation to smoking.
Our aim is to show that COHb levels can be used to discriminate between persons having certain atherosclerotic diseases and persons without these diseases more accurately than is possible by using smoking history alone, and thus to suggest that this may be a good indicator of risk.
Methods
This paper is based on data collected by one of us (K.K.) as part of an epidemiological investigation of COHb and serum cholesterol in Danish smokers (Kjeldsen, 1969) .
A total of 1,085 volunteers who worked for several firms in Copenhagen, including three tobacco companies, responded to an appeal for help in a study of arterial disease and smoking. Each subject completed a questionnaire about his smoking habits and any past medical history of vascular disease. All those giving a history suggestive of vascular disease were examined and the presence of myocardial infarction, angina pectoris, or intermittent claudication was confirmed from past medical records using the criteria shown in table I. Venous blood samples were taken from 1,083 people (two refused) at about the same time of the day (after lunch) and after the subjects had smoked as usual that day. Serum cholesterol and blood CO estimations were performed on each blood sample. Serum cholesterol was estimated by the method described by Richterich (1965) The proportion of affected persons classified by COHb level and total tobacco consumption is given in table IV. Light smokers rarely have high COHb levels, but heavy smokers frequently have low COHb levels. The proportion of affected persons increases with increasing COHb levels and, to a lesser extent, with increasing tobacco consumption. The relative Multiple regression analysis (using a logistic model with linear effects (Cox, 1970) ) was used to investigate the relation between the proportion of affected persons and sex, age, years of past smoking, amount of cigarettes, amount of cigars, and amount of pipe tobacco smoked (each type of tobacco divided into the light, moderate, and heavy categories), serum cholesterol (mg/100 ml), and COHb level in 0 5% gradations. The analysis which was restricted to the 625 smokers who were aged 30-69 years (since all the affected subjects were in this age range) showed that the only significant factors associated with the specified diseases were age, serum cholesterol, and COHb.
The residual effect of all the remaining factors after allowing for age, COHb, and serum cholesterol was not significant (table V) . X' (5 D.F.) = 12-84, Xs (1 D.F.-trend) = 12-30, P <0-001. These significance tests were performed with COHb grouped into six categories; these have been condensed for presentation. The tests were based on the method described by Armitage (1966) . The COHb effect was more pronounced in persons with a short smoking history. After allowing for the effects of smoking history and serum cholesterol and their interaction, the effect of COHb was still statistically highly significant (P < 0O0005).
RELATIVE RISK
High COHb levels were found to be strongly associated with an increased frequency of atherosclerotic disease. All the 625 subjects used in the regression analysis on smokers of all types of tobacco were divided into groups matched by sex, age (in decades), years of smoking (in decades), and consumption of cigarette, cigar, and pipe tobacco. Type of tobacco was matched exactly. Forty-three of the groups, with 208 people in all, contained at least one affected person. From these matched groups the maximum likelihood estimate of relative risk was obtained in a manner similar to that given by Miettinen (1970) . The relative risk for persons with COHb levels of-5 % or more compared with persons with less than 3 0% COHb was 21 2 (95 % confidence limits 3-3, 734-3). The magnitude of risk did not vary significantly for different types of tobacco or for age or sex. The risk was similar in magnitude with respect to ischaemic heart disease and intermittent claudication.
Discussion
COHb was highly significantly associated with ischaemic heart disease and intermittent claudication even after allowing for serum cholesterol, age, and smoking history, which are known toJ be related to these diseases (Kannel et al., 1964 (Kannel et al., , 1967 . The independent association of COHb level and atherosclerotic disease has not previously been reported and its strength suggests that raised COHb levels may be an important risk factor in atherosclerosis, including ischaemic heart disease. This does not mean, necessarily, that CO itself is atherogenic, although there is experimental evidence in animals, including primates, that this is the case (Webster et al., 1970; Kjeldsen et al., 1972) . CO is nonetheless a useful marker of tobacco smoke absorption, and our data suggest that it is at least an indirect measure of the risk of ischaemic disorders.
In this study the time of venesection for COHb estimation was only approximately standardized in relation to the time of smoking. Nevertheless, of all the factors considered, COHb was still the most powerful discriminator between affected and unaffected persons.
There is no way, a priori, of knowing how to equate precisely the weight of tobacco smoked in cigarettes with that smoked in cigars or pipes in terms of the risk of ischaemic disorders. Unless data from mixed smokers are to be overlooked, some assumption regarding the relative equivalence of different types of tobacco seems to be justified. Alternative reasonable assumptions about the relative equivalence of the three types of tobacco were made and did not materially alter the results.
It could be argued that the sample population from which these data were collected was not representative because it consisted of volunteers and a high proportion of tobacco factory workers. Neither of these facts, however, is likely to affect the observed association between high COHb levels and atherosclerotic disease. The high proportion of cigar smokers, 34% of whom were women, is clearly more typical of Denmark than Britain.
The results of the three analyses are consistent in showing a strong independent association between COHb and the specified atherosclerotic diseases but give divergent results regarding the effects of cholesterol and smoking history when cigarette and cigar smokers are examined separately. These divergent results probably reflect the peculiar sample population and the variability in the data, and we think that they should be interpreted cautiously. A greater effect of current tobacco consumption on the frequency of atherosclerotic diseases might have been detected (after allowing for the effect of COHb) had it been possible to use smaller and more refined categories. Data from a cross-sectional study in which affected subjects were aware of their disease cannot be used to predict atherosclerotic disease. It is possible that as a result of these diseases subjects altered their smoking habits so as to lead to higher COHb levels for a given cigarette consumption. This might occur if cigarettes were inhaled more deeply to compensate for a reduction prompted by medical advice. Though there is no way of determining whether such selective factors have produced a spurious association, the results suggest a strong association between bigh COHb levels and certain atherosclerotic diseases. We believe that this warrants further investigation by a prospective study, and this is now being undertaken in Oxford and London.
Introduction
There have been several reports of changes in the relative proportions of saturated and unsaturated fatty acids in the brain lipids in multiple sclerosis (Gerstl et al., 1961; Baker et al., 1963; Cumings et al., 1965; Arnetoli et al., 1969; Clausen and Hansen, 1970; Gerstl et al., 1970; Alling et al., 1971) and also that the serum linoleate level is reduced in this desease (Baker et al., 1964; Tichy et al., 1969; Malhler, 1971) . The
